Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Neuroradiology
Published in: Clinical Neuroradiology 3/2013

01-09-2013 | Original Article

Quantitative T2 Measurements in Juvenile and Late Infantile Neuronal Ceroid Lipofuscinosis

Authors: Alvaro Paniagua Bravo, MD, N. D. Forkert, A. Schulz, MD, U. Löbel, MD, J. Fiehler, MD, X. Ding, MD, PhD, J. Sedlacik, PhD, M. Rosenkranz, MD, E. Goebell, MD

Published in: Clinical Neuroradiology | Issue 3/2013

Login to get access

Abstract

Purpose

The two most prevalent forms of neuronal ceroid lipofuscinosis (NCL) are the juvenile form (Batten disease, CLN3) and late infantile form (Jansky–Bielschowsky disease, CLN2). The aim of this study was to compare quantitative T2-values of brain tissue in CLN2 and CLN3 patients with reference values from age-matched normal subjects.

Methods

Twenty-three CLN2 (n = 6) and CLN3 (n = 17) patients (m:f = 11:12) underwent MRI examination including a multiecho T2 sequence. Quantitative T2-values were measured in six defined regions of interest (ROIs) in the calculated quantitative T2 maps within the white matter (WM) and gray matter (GM). The extracted quantitative T2-values were compared with reference values from healthy children and young adults. Informed consent was obtained from the patients or their parents for all patients.

Results

Statistical analysis revealed elevated quantitative T2-values in nearly all ROIs placed in the WM of the CLN2 patients. In contrast to this finding, no significant differences were found for the quantitative T2-values of the CLN3 patients compared to the age-matched healthy controls in any of the defined WM ROIs. Both groups exhibited no significant alterations of the quantitative T2-values in the GM ROIs compared to the healthy subjects.

Conclusion

Alterations of quantitative T2-values in the cerebral WM may not be a reliable sign to confirm the diagnosis in CLN3 patients but could prove valuable for diagnosis confirmation, follow-up examinations, and longitudinal monitoring of the disease progression in CLN2 patients.
Literature
1.
Uvebrant P, Hagberg B. Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics. 1997;28(1):6–8.PubMedCrossRef
2.
Goebel HH, Wisniewski KE. Current state of clinical and morphological features in human NCL. Brain Pathol. 2004;14(1):61–9.PubMedCrossRef
3.
Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003;62(1):1–13.PubMed
4.
Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6(3):107–26. doi:10.1007/s10048-005-0218-3.PubMedCrossRef
5.
D’Incerti L. MRI in neuronal ceroid lipofuscinosis. Neurol Sci. 2000;21(3 Suppl):S71–73.
6.
Autti T, Raininko R, Vanhanen SL, Santavuori P. Magnetic resonance techniques in neuronal ceroid lipofuscinoses and some other lysosomal diseases affecting the brain. Curr Opin Neurol. 1997;10(6):519–24.PubMedCrossRef
7.
Autti T, Raininko R, Vanhanen SL, Santavuori P. MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology. 1996;38(5):476–82.PubMedCrossRef
8.
Santavuori P, Vanhanen SL, Autti T. Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol. 2001;5(Suppl A):157–61.PubMedCrossRef
9.
Ding XQ, Kucinski T, Wittkugel O, Goebell E, Grzyska U, Gorg M, et al. Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use. Invest Radiol. 2004;39(12):740–6.PubMedCrossRef
10.
Ding XQ, Wittkugel O, Goebell E, Forster AF, Grzyska U, Zeumer H, et al. Clinical applications of quantitative T2 determination: a complementary MRI tool for routine diagnosis of suspected myelination disorders. Eur J Paediatr Neurol. 2008;12(4):298–308. doi:S1090-3798(07)00160-2.PubMedCrossRef
11.
Bauer CM, Jara H, Killiany R. Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: applications to AD, MCI, and normal aging. Neuroimage. 2010;52(2):508–14.PubMedCrossRef
12.
Autti T, Raininko R, Santavuori P, Vanhanen SL, Poutanen VP, Haltia M. MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type. Neuroradiology. 1997;39(5):371–7.PubMedCrossRef
13.
Dyke JP, Voss HU, Sondhi D, Hackett NR, Worgall S, Heier LA, et al. Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imaging. AJNR Am J Neuroradiol. 2007;28(7):1232–6.PubMedCrossRef
14.
Seitz D, Grodd W, Schwab A, Seeger U, Klose U, Nagele T. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol. 1998;19(7):1373–7.PubMed
15.
Marshall FJ, de Blieck EA, Mink JW, Dure L, Adams H, Messing S, et al. A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology. 2005;65(2):275–9.PubMedCrossRef
16.
Worgall S, Kekatpure MV, Heier L, Ballon D, Dyke JP, Shungu D, et al. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis. Neurology. 2007;69(6):521–35.PubMedCrossRef
17.
Goebell E, Fiehler J, Siemonsen S, Vaeterlein O, Heese O, Hagel C, et al. Macromolecule content influences proton diffusibility in gliomas. Eur Radiol. 2011;21(12):2626–32.PubMedCrossRef
18.
Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. AJR Am J Roentgenol. 1986;147(1):103–10.PubMedCrossRef
19.
Vanhanen SL, Raininko R, Santavuori P, Autti T, Haltia M. MRI evaluation of the brain in infantile neuronal ceroid-lipofuscinosis. Part 1: Postmortem MRI with histopathologic correlation. J Child Neurol. 1995;10(6):438–43.PubMedCrossRef
20.
Autti T, Joensuu R, Aberg L. Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology. 2007;49(7):571–8.PubMedCrossRef
Metadata
Title
Quantitative T2 Measurements in Juvenile and Late Infantile Neuronal Ceroid Lipofuscinosis
Authors
Alvaro Paniagua Bravo, MD
N. D. Forkert
A. Schulz, MD
U. Löbel, MD
J. Fiehler, MD
X. Ding, MD, PhD
J. Sedlacik, PhD
M. Rosenkranz, MD
E. Goebell, MD
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 3/2013
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-012-0189-3

Other articles of this Issue 3/2013

Clinical Neuroradiology 3/2013 Go to the issue

Original Article

Quantification of Phase Values of Cerebral Microbleeds in Hypertensive Patients Using ESWAN MRI

Clinical Case

Freiburg Neuropathology Case Conference: A Contrast-Enhancing Orbital, Intra-Conal Lesion

Information

Societies Communications

Editorial

We’re on the Right Path…

Correspondence

Lacrimo-Auriculo-Dento-Digital Syndrome with Unilateral Inner Ear Dysplasia and Craniocervical Osseous Abnormalities: Case Report and Review of Literature

New in the Web

Everything You Always Wanted to Know About Cone Beam Computed Tomography: 3D-Roentgen.ch